Novavax Inc (NVAX) stock
NVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$7.96+0.00 (0.00%)
Close on Nov 18, 2026Market cap $1.31BP/E –Yield –
Novavax total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
For fiscal 2015 it was $395.00K, down 60.4% from the year before. The highest annual figure on record is $1.88M in fiscal 2013.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $395.00K | -60.4% |
| FY2014 | Dec 31, 2014 | $998.00K | -46.9% |
| FY2013 | Dec 31, 2013 | $1.88M | +149.8% |
| FY2012 | Dec 31, 2012 | $753.00K | +151.0% |
| FY2011 | Dec 31, 2011 | $300.00K | -6.3% |
| FY2010 | Dec 31, 2010 | $320.00K | – |
See a number that looks wrong?